Vaccinia Virus antibody
Rabbit anti Vaccinia Virus
- Product Type
- Polyclonal Antibody
- Isotype
- Polyclonal IgG
- Specificity
- Vaccinia Virus
Rabbit anti vaccinia virus antibody recognizes vaccinia virus purified virions. It reacts with Lister and NYCBOH strains of Vaccinia. It does not cross react with Parainfluenza (1-3), RSV, Adenovirus, Influenza A+B, or HSV. |
- Target Species
- Viral
- Product Form
- Purified IgG - liquid
- Buffer Solution
- Phosphate buffered saline
- Preservative Stabilisers
- 0.1% Sodium Azide (NaN3)
- Immunogen
- Vaccinia virus, New York City Board of Health (NYCBOH) strain.
- Approx. Protein Concentrations
- IgG concentration 5 mg/ml
- Regulatory
- For research purposes only
- Guarantee
- 12 months from date of despatch
Avoid repeated freezing and thawing as this may denature the antibody. Storage in frost-free freezers is not recommended.
Application Name | Verified | Min Dilution | Max Dilution |
---|---|---|---|
ELISA | |||
Immunohistology - Frozen |
Description | Product Code | Applications | Pack Size | List Price | Your Price | Quantity | |
---|---|---|---|---|---|---|---|
Goat anti Rabbit IgG (Fc):Biotin | STAR121B | E WB | 1 mg | Log in | |||
List Price | Your Price | ||||||
Log in | |||||||
Description | Goat anti Rabbit IgG (Fc):Biotin | ||||||
Goat anti Rabbit IgG (Fc):FITC | STAR121F | F | 1 mg | Log in | |||
List Price | Your Price | ||||||
Log in | |||||||
Description | Goat anti Rabbit IgG (Fc):FITC | ||||||
Goat anti Rabbit IgG (Fc):HRP | STAR121P | E WB | 1 mg | Log in | |||
List Price | Your Price | ||||||
Log in | |||||||
Description | Goat anti Rabbit IgG (Fc):HRP | ||||||
Goat anti Rabbit IgG (H/L):HRP | STAR124P | C E WB | 1 mg | Log in | |||
List Price | Your Price | ||||||
Log in | |||||||
Description | Goat anti Rabbit IgG (H/L):HRP | ||||||
Sheep anti Rabbit IgG:RPE | STAR35A | F | 1 ml | Log in | |||
List Price | Your Price | ||||||
Log in | |||||||
Description | Sheep anti Rabbit IgG:RPE |
References for Vaccinia Virus antibody
-
Hornemann, S. et al. (2003) Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.
J Virol. 77 (15): 8394-407. -
Vogel, T.U. et al. (2003) Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239.
J Virol. 77: 13348-60. -
Staib, C. et al. (2004) Construction and isolation of recombinant MVA.
Methods Mol Biol. 269: 77-100. -
Olszewska, W. et al. (2004) Protective and disease-enhancing immune responses induced by recombinant modified vaccinia Ankara (MVA) expressing respiratory syncytial virus proteins.
Vaccine. 23: 215-21. -
Manuel, E.R. et al. (2010) Intergenic region 3 of modified vaccinia ankara is a functional site for insert gene expression and allows for potent antigen-specific immune responses.
Virology. 2010 403: 155-62. -
Buttigieg, K.R. et al. (2014) A Novel Vaccine against Crimean-Congo Haemorrhagic Fever Protects 100% of Animals against Lethal Challenge in a Mouse Model.
PLoS One. 9(3):e91516. -
Kennedy, E.M. et al. (2019) A vaccine based on recombinant modified Vaccinia Ankara containing the nucleoprotein from Lassa virus protects against disease progression in a guinea pig model.
Vaccine. 37 (36): 5404-5413. -
Zhang, Z. et al. (2020) Treatment and Prevention of Lung Cancer Using a Virus-Infected Reprogrammed Somatic Cell-Derived Tumor Cell Vaccination (VIReST) Regime.
Front Immunol. 11: 1996.
View The Latest Product References
- RRID
- AB_619589
Please Note: All Products are "FOR RESEARCH PURPOSES ONLY"
View all Anti-Viral ProductsAlways be the first to know.
When we launch new products and resources to help you achieve more in the lab.
Yes, sign me up